Natixis Advisors LLC Has $6.64 Million Stock Holdings in Tenet Healthcare Co. (NYSE:THC)

Natixis Advisors LLC boosted its holdings in Tenet Healthcare Co. (NYSE:THC) by 19.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 39,948 shares of the company’s stock after purchasing an additional 6,491 shares during the period. Natixis Advisors LLC’s holdings in Tenet Healthcare were worth $6,639,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Innealta Capital LLC acquired a new position in Tenet Healthcare during the 2nd quarter valued at $28,000. Plato Investment Management Ltd bought a new stake in shares of Tenet Healthcare in the third quarter valued at about $28,000. ORG Wealth Partners LLC bought a new position in Tenet Healthcare during the third quarter valued at about $30,000. ORG Partners LLC bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $31,000. Finally, Blue Trust Inc. increased its position in shares of Tenet Healthcare by 93.0% during the second quarter. Blue Trust Inc. now owns 249 shares of the company’s stock valued at $33,000 after purchasing an additional 120 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Lisa Y. Foo sold 4,000 shares of the firm’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $155.94, for a total value of $623,760.00. Following the transaction, the executive vice president now directly owns 15,566 shares in the company, valued at $2,427,362.04. This trade represents a 20.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider R. Scott Ramsey sold 11,599 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $162.06, for a total value of $1,879,733.94. Following the completion of the sale, the insider now owns 6,324 shares of the company’s stock, valued at $1,024,867.44. This represents a 64.72 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,599 shares of company stock valued at $2,830,834. 0.93% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Tenet Healthcare from $195.00 to $205.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. The Goldman Sachs Group upped their target price on shares of Tenet Healthcare from $173.00 to $196.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. KeyCorp initiated coverage on shares of Tenet Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $200.00 price target for the company. Cantor Fitzgerald increased their target price on Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a report on Wednesday, October 30th. Finally, UBS Group upped their price target on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $171.63.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $143.57 on Friday. The firm has a 50 day simple moving average of $158.86 and a 200 day simple moving average of $147.87. Tenet Healthcare Co. has a fifty-two week low of $65.90 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52. The firm has a market cap of $13.65 billion, a P/E ratio of 4.60, a P/E/G ratio of 0.69 and a beta of 2.15.

Tenet Healthcare (NYSE:THC) last released its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.44 earnings per share. Sell-side analysts predict that Tenet Healthcare Co. will post 11.38 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.